Positive initial data on first mRNA therapy for propionic acidemia
Drug Discovery World
MAY 24, 2023
Moderna has reported encouraging interim data from its Phase I/II trial of mRNA-3927, an mRNA therapy for rare metabolic disorder propionic acidemia (PA). The data was presented at the 2023 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting.
Let's personalize your content